Lilly's Kisunla™ (Donanemab-Azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease
FDA批准Lilly的Kisunla™ (Donanemab-Azbt)用於治療早期症狀的阿爾茨海默病
Lilly's Kisunla™ (Donanemab-Azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease
FDA批准Lilly的Kisunla™ (Donanemab-Azbt)用於治療早期症狀的阿爾茨海默病
譯文內容由第三人軟體翻譯。